Exclusive: Top drug regulator Richard Pazdur set to leave FDA

Pazdur has filed paperwork to retire, but could withdraw it, sources say.

Log In    Subscribe EXCLUSIVE   Top drug regulator Richard Pazdur set to leave FDA By Lizzy Lawrence FDA Top drug regulator Richard Pazdur filed papers to retire from the FDA at the end of this month, according to two agency sources familiar with the matter.   Pazdur informed leaders at the FDA's drug center of his intention to leave the agency at a meeting on Tuesday. He could still retract the papers. The move comes less than a month after he took the role at the urging of FDA Commissioner Marty Makary. READ MORE Sign up for Daily Recap All the health and medical news you need today, in one email. Learn more. In Case You Missed It 1   Experts say top FDA official's claim that Covid vaccines caused kids' deaths requires more evidence By Matthew Herper and Helen Branswell 2   Exclusive: FDA review staff was excluded from voting on whether to approve first priority voucher drug By Lizzy Lawrence 3   Exclusive: How two top FDA officials are quietly upending vaccine regulations By Lizzy Lawrence 4   Exclusive: CDC staff with disabilities feel stranded as HHS implements new policy By O. Rose Broderick Get your first 6 months of STAT+ for $20 Unlock in-depth analysis of biopharma and the life sciences. Learn more STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails Update Newsletter Preferences • Contact Us • Advertise with Us